ANP-020

N/A

Report date: 2025/01/26 19:13:28

Base Information

Drug NameANP-020
Drug Alias Nameanti-PSMA antibody-drug conjugate (ANP)ANP-020
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionProstate-specific antigen inhibitors
TargetsProstate-specific antigen
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesANP Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesANP Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A